We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » SENIORS: LIMIT DRUGMAKERS' ROLE IN MEDICARE Rx
SENIORS: LIMIT DRUGMAKERS' ROLE IN MEDICARE Rx
November 12, 2004
Pharmaceutical firms shouldn't be allowed to determine what drugs the Medicare program will pay for under the new Rx benefit, according to seniors surveyed by the trade group representing pharmaceutical benefit managers (PBMs).